UK Extends Recognition Of EU Batch Testing Pending Review
Industry Welcomes ‘Pragmatic’ Move
Executive Summary
Having to set up duplicate testing facilities in the EU and the UK is an expensive business, so pharmaceutical companies are relieved that the UK is giving them some extra breathing space.